Disclosed embodiments relate to apparatuses and methods for wound treatment with ultrasound. In certain embodiments, therapeutic ultrasound wound treatment apparatus includes a wound dressing configured to be positioned over a wound to provide a substantially fluid impermeable seal over the wound and a transducer to deliver therapeutic ultrasound to tissue. The therapeutic ultrasound wound treatment apparatus may further include a wound contact layer configured to be positioned in contact with the wound, a transmission layer positioned above the wound contact layer, an absorbent layer positioned above the transmission layer and configured to absorb wound fluid, and a backing layer positioned above the absorbent layer and including an orifice. Also disclosed are multiple parameters for the therapeutic ultrasound signal.

Adhesive bandages/shield/cover with at least one raised non-adhesive portion which is elevated above the at least one adhesive layer with attached water temperature gauge indicator. The raised non-adhesive portion is peripherally surrounded by an adhesive layer with attached water temperature gauge indicator and is designed to protect surgical sites and cutaneous wounds as well as any other skin malady. Neither the raised non-adhesive portions of the bandage/shield/cover nor the adhesive layer with attached water temperature gauge indicator are in contact with the cutaneous layer which is the subject of the sought protection, with the adhesive layer with attached water gauge temperature indicator coming into contact only with the area surrounding the affected site which can result in the reduction or elimination of exposure to moisture and/or contaminates, and the correct water temperature can be indicated to eliminate any scalding of the skin. In addition, the surgical site or cutaneous wound is protected from force or impact. The raised non-adhesive portion may also be transparent to provide for monitoring of the surgical site or cutaneous wound while the surgical site or cutaneous wound remains protected.

The present invention relates to a device and a method. The device of the present invention comprising a patch comprising: a substrate, and an adhesive on the substrate. Further, the patch is configured to be attached to a skin via the adhesive to form a pocket between the patch and the skin, to allow introduction of a material into the pocket, and to hold the material within the pocket.

A hemostasis device comprises a panel having a top side and a bottom side having an adhesive layer coupled to the panel. A button, having a 3-dimensional shape, is integrally molded to the top side of the panel. One or more apertures extend through the button and the panel. A pad joined to the panel by the adhesive layer. The button is engaged to a wound by a user and adapted to provide a force vector in a substantially axial direction to the wound. A method for imparting hemostasis comprises the steps of selecting an arterial pressure device then positioning the button with the one or more apertures over a wound. Retaining the device over the wound imparts a force vector in a substantially axial direction to the wound and results in more rapid blood coagulation.

A transdermal therapeutic system for administering at least one active pharmaceutical ingredient, including a polymer-based layer which is remote from the skin with a rate of application of at least 80 g/m.sup.2, and an adhesive skin-contact layer which is adjacent to the polymer-based layer remote from the skin and is based on acrylate copolymers with a rate of application of not more than 50 g/m.sup.2. The at least one active pharmaceutical ingredient is present in both the polymer-based layer remote from the skin and the skin-contact layer.

Devices, bandages, kits and methods are described that can control or regulate the mechanical environment of a wound to ameliorate scar and/or keloid formation. The mechanical environment of a wound includes stress, strain, and any combination of stress and strain. The control of a wound's mechanical environment can be active, passive, dynamic, or static. The devices are configured to be removably secured to a skin surface in proximity to the wound site and shield the wound from endogenous and/or exogenous stress.

Implementations of a medical pad comprise a perimeter side, a first surface, a second surface, and a plurality of openings. In some implementations, a method of using the medical pad comprises positioning the medical pad on an area susceptible to the development of a bedsore or similar wound, such as a bony prominence or pressure point, to prevent the development of a bedsore or similar wound, and another method comprises positioning the medical pad on a bedsore or similar wound to help the treatment and healing of the bedsore or similar wound.

A flexible hemostatic pad formed from a hemostatic powder, which may contain a hydrophilic polymer such as a cation ion exchange resin, compressed onto or into a velvet-like backing substrate is provided for the control of bleeding at a wound site.

When thin-film dressings are used to secure a device, the dressing might need to stretch in some areas to accommodate varying sizes of a device, while remaining stiffer in some areas to limit stretching of the materials. Excessive stretching of the materials can cause the dressing to peel away from the skin or cause the underlying device to not be sufficiently secured. The disclosed dressing can be used to secure a device and includes perforations near the device securement area to allow for isolated regions of adjustability to accommodate a secure fit between the dressing and device.

A wound closure device includes an elastic substrate and a plurality of microstructure arrays coupled to the elastic substrate via an adhesive layer. The device is long enough or wide enough to treat large wounds with the plurality of microstructure arrays distributed along a length of the wound.